483 Strides Pharma Science Feb 2016

483 Strides Pharma Science Feb 2016

Scott Ballard FDA$119.00 - Available Now

FDA investigators audited the Strides Pharma Science - Bangalore, India facility and issued 2 inspectional observations (via FDA 483) on 19 Feb 2016.

Product details

  • Category: Human Drugs
  • Number of Observations: 2
  • Inspection end: 19 Feb 2016
  • Location: Bangalore, India
  • FEI: 3004554612
Add To Cart